Revenue: USD 3.96 billion (up 11% from Q3 2023).
Net profit: USD 258.7 million (55% increase compared to Q3 2023).
Margin: 6.5% (up from 4.7% in Q3 2023). The increase in margin was driven by an increase in revenue.
EPS: USD 3.89 (up from USD 2.42 in Q3 2023).
Profit and revenue growth
All numbers shown in the chart above are for the trailing 12 month (TTM) period.
Sales exceeded analysts’ expectations by 1.5%. Earnings per share (EPS) also exceeded analyst expectations by 3.0%.
Looking ahead, revenues are expected to increase by an average of 5.5% per year over the next three years, compared to a growth forecast of 6.6% for the U.S. healthcare industry.
Performance of the American healthcare industry.
The company’s stock price has fallen 14% from a week ago.
You should learn about the 1 warning sign we’ve spotted with Universal Health Services.
Do you have feedback on this article? Interested in its content? Please contact us directly. Alternatively, email our editorial team at Simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts using only unbiased methodologies, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
